Cantor Fitzgerald Downgrades Asensus Surgical to Neutral
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has downgraded Asensus Surgical (AMEX:ASXC) from Overweight to Neutral, indicating a change in the firm's outlook on the company's stock.

November 16, 2023 | 11:12 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Asensus Surgical was downgraded by Cantor Fitzgerald from Overweight to Neutral, which may lead to a negative perception among investors and could impact the stock price negatively in the short term.
Downgrades by analysts, such as the one from Cantor Fitzgerald, often lead to a decrease in investor confidence and can result in a short-term decline in the stock price. Given that the downgrade is from Overweight to Neutral, it suggests a significant shift in the firm's view on the stock's potential, which is likely to be taken seriously by the market.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100